Clinical Trial: International Collaborative Gaucher Group (ICGG) Gaucher Registry
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: International Collaborative Gaucher Group (ICGG) Gaucher Registry
Brief Summary:
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The objectives of the Registry are:
- To enhance the understanding of the variability, progression, and natural history of Gaucher disease with the ultimate goal of better guiding and assessing therapeutic interventions;
- To provide the Gaucher medical community with recommendations for monitoring patients and to provide reports on patient outcomes to help optimize patient care; and
- To evaluate the long-term effectiveness of Cerezyme.
Detailed Summary:
Sponsor: Genzyme, a Sanofi Company
Current Primary Outcome: To provide the Gaucher medical community with recommendations for monitoring patients and to provide reports on patient outcomes to help optimize patient care. [ Time Frame: For duration of the study ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Sanofi
Dates:
Date Received: July 12, 2006
Date Started: April 1991
Date Completion: January 2030
Last Updated: February 18, 2016
Last Verified: February 2016
